This report sets out a clear perspective on the next phase of growth for India’s MedTech sector. After a period of strong momentum marked by rising domestic manufacturing, increasing exports, and growing policy and investor support, India has demonstrated its potential to evolve from an import-dependent market into a globally competitive manufacturing and innovation hub.
As the sector scales toward a ~$41–44 billion opportunity by 2030 and up to ~$83–89 billion by 2035, the challenge shifts from growth to execution. Incremental improvements will not suffice, as structural gaps across components, regulatory pathways, and innovation investment require a step change in how the industry builds and competes globally.
The report frames this transformation across two parallel imperatives: “Make in India” and “Innovate in India”. It identifies where India has a clear right to win today, where capabilities must be built over time, and how both domestic players and MNCs can leverage India as a strategic manufacturing and innovation base.
Drawing on industry inputs, company data, and policy sources, the report translates these insights into an execution-led roadmap. It highlights priority actions across value chain localization, regulatory enablement, ecosystem partnerships, talent and capital development, and targeted efforts to attract global OEMs.
Together, these priorities position India to convert its structural advantages into a durable global role and emerge as a trusted, future-ready MedTech hub.